Atlas Trials

Study of Curcumin, Vorinostat, and Sorafenib

Clinical trial NCT01608139 · WITHDRAWN

Trial details

NCT number
NCT01608139
Sponsor
M.D. Anderson Cancer Center
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Cancers
Start date
2012-11-01
Primary completion
2022-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.